New eye drops aim to speed healing after laser surgery
NCT ID NCT06854393
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 trial tests whether Lacripep eye drops can help the cornea heal faster and more smoothly after PRK laser eye surgery. 88 active-duty military members and their dependents will receive Lacripep in one eye and a placebo in the other. The study measures corneal thickness and vision recovery to see if the drug is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lacripep ophthalmic solution (0.00025%)
- What this could lead to
- If it works, this could provide a new eye drop to help the cornea heal faster and more completely after laser eye surgery.
- What could go wrong
- This is an early Phase 2 trial with only 88 people, so results may not apply to everyone. The treatment is compared to placebo in the same person, and long-term safety is not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEAL EPITHELIAL WOUND HEALING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alexander T. Augusta Military Medical Center
RECRUITINGFort Belvoir, Virginia, 22060, United States